Gleb Filippov, MD

Effectiveness and Safety of Lemborexant in Subjects Previously Treated with Placebo for 6 Months in SUNRISE-2

Introduction: In Study 303 (SUNRISE-2; NCT02952820), while lemborexant (LEM) provided significant benefit versus placebo (PBO) on sleep-diary measurements over 6mo, some improvement was ...

Margaret Moline , PhD;

Yuichi Inoue , MD, PhD;

Carlos Perdomo , MSc;

Jane Yardley , PhD;

Gleb Filippov , MD;

Kate Pinner , MSc;

Naoki Kubota ;

10/08/2020

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Gleb Filippov, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products